Fidelity Investments
QNTM

Fidelity Investments’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Fidelity Investments’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$4 – 5858
2024
Q3 		$4 Buy
+1
New +$6 ﹤0.01% 5461

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Fidelity Investments's QNTM Position: Q4 2024 in Review

Fidelity Investments sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q4 2024, closing a stake of 1 share — an estimated $4 sold.

Fidelity Investments first reported a position in QNTM in Q3 2024 and held it in 1 quarter. The position peaked at $4 in Q3 2024. 9 funds tracked by Wall St. Rank hold QNTM as of Q4 2024.

  • Fidelity Investments reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q4 2024 after selling out during the quarter.
  • Fidelity Investments sold 1 Quantum Biopharma Class B Subordinate Voting Shares share in Q4 2024, an estimated $4.
  • Fidelity Investments first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q3 2024 and held it in 1 quarter.
  • Fidelity Investments's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $4 in Q3 2024.
  • 9 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q4 2024.

Based on Fidelity Investments's 13F filing for Q4 2024, filed 13 Feb 2025.